📰 John Temperato News
John Temperato News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Temperato. Real-time updates on events, politics, business and more.
May 30, 2023
RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced
May 15, 2023
9 Meters Biopharma Provides Business Update and Reports Financial Results ...
May 15, 2023
RALEIGH, NC / ACCESSWIRE / May 15, 2023 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided
April 5, 2023
RALEIGH, NC / ACCESSWIRE / April 5, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced
April 5, 2023
9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding ...
March 28, 2023
9 Meters Biopharma Provides Business Update and Reports Financial Results ...
March 7, 2023
RALEIGH, NC / ACCESSWIRE / March 7, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced
November 29, 2022
Study design incorporates two primary endpoints to evaluate the efficacy of vurolenatide in short bowel syndrome with or without parenteral support dependenceStudy design allows for the assessment of the
September 6, 2022
RALEIGH, NC / ACCESSWIRE / September 6, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced
August 15, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.